Detalhe da pesquisa
1.
Comparative Immune Response after Vaccination with SOBERANA® 02 and SOBERANA® plus Heterologous Scheme and Natural Infection in Young Children.
Vaccines (Basel)
; 11(11)2023 Oct 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38005968
2.
Safety and immunogenicity of anti-SARS CoV-2 vaccine SOBERANA 02 in homologous or heterologous scheme: Open label phase I and phase IIa clinical trials.
Vaccine
; 40(31): 4220-4230, 2022 07 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-35691871
3.
Estudio de intervención con SOBERANA® en los trabajadores del Centro Nacional de Biopreparados / Intervention study with SOBERANA® in the workers of the Centro Nacional de Biopreparados
Vaccimonitor (La Habana, Print)
; 31(2)ago. 2022.
Artigo
em Espanhol
| LILACS, CUMED | ID: biblio-1410304